MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
PHAR Pharming Group
- 9.100
- +0.160+1.79%
Close Dec 20 16:00 ET
617.30MMarket Cap-33.70P/E (TTM)
9.270High9.050Low3.82KVolume9.100Open8.940Pre Close34.98KTurnover0.01%Turnover RatioLossP/E (Static)67.84MShares13.20052wk High2.73P/B597.48MFloat Cap6.65052wk Low--Dividend TTM65.66MShs Float21.990Historical High--Div YieldTTM2.46%Amplitude6.100Historical Low9.168Avg Price1Lot Size
Pharming Group Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.28%74.85M | 34.97%74.09M | 30.66%55.59M | 19.30%245.32M | 48.69%81.22M | 22.90%66.66M | 9.47%54.9M | -8.74%42.54M | 3.39%205.62M | 3.51%54.62M |
| Operating revenue | 12.28%74.85M | 34.97%74.09M | 30.66%55.59M | 19.30%245.32M | 48.69%81.22M | 22.90%66.66M | 9.47%54.9M | -8.74%42.54M | 3.39%205.62M | 3.51%54.62M |
| Cost of revenue | -17.79%6.82M | 39.43%7.98M | 105.79%8.39M | 43.56%25.21M | 13.45%7.12M | 248.24%8.3M | 42.07%5.72M | -16.44%4.08M | -16.93%17.56M | 11.20%6.27M |
| Gross profit | 16.56%68.03M | 34.45%66.11M | 22.71%47.2M | 17.04%220.1M | 53.26%74.1M | 12.56%58.37M | 6.63%49.17M | -7.84%38.47M | 5.81%188.06M | 2.59%48.35M |
| Operating expense | 13.22%63.92M | 57.80%69.23M | 21.84%63.51M | 36.02%242.39M | 34.43%89.93M | 28.05%56.46M | 55.05%43.87M | 33.96%52.13M | 12.27%178.2M | 53.95%66.9M |
| Selling and administrative expenses | 22.13%43.98M | 8.15%48.55M | 22.24%45.34M | 27.08%87.5M | -85.74%-30.48M | 11.16%36.01M | 60.63%44.89M | 48.80%37.09M | 43.07%68.85M | 10.15%-16.41M |
| -Selling and marketing expense | 14.18%28.69M | -2.88%32.93M | 11.59%30.25M | 6.35%6.82M | -57.35%-79.32M | 23.33%25.12M | 76.12%33.91M | 57.63%27.11M | 266.50%6.41M | -19.65%-50.41M |
| -General and administrative expense | 40.47%15.29M | 42.23%15.62M | 51.16%15.09M | 29.21%80.68M | 43.65%48.84M | -9.47%10.89M | 26.33%10.98M | 29.15%9.98M | 34.65%62.44M | 42.45%34M |
| Research and development costs | -0.15%20.72M | 3.27%21.6M | 18.57%18.52M | 31.19%68.91M | 6.75%11.63M | 68.14%20.75M | 44.90%20.91M | 5.09%15.62M | -25.35%52.53M | -44.67%10.89M |
| Depreciation amortization depletion | ---- | ---- | ---- | 27.98%9.16M | ---- | ---- | ---- | ---- | 21.56%7.15M | ---- |
| -Depreciation and amortization | ---- | ---- | ---- | 27.98%9.16M | ---- | ---- | ---- | ---- | 21.56%7.15M | ---- |
| Other operating expenses | -155.59%-777K | 95.84%-912K | 40.41%-345K | 54.69%76.82M | 52.66%99.63M | 53.01%-304K | -55.72%-21.93M | 33.68%-579K | 44.61%49.66M | 80.54%65.26M |
| Operating profit | 115.30%4.11M | -158.90%-3.12M | -19.39%-16.31M | -326.05%-22.29M | 14.65%-15.83M | -75.43%1.91M | -70.27%5.3M | -583.65%-13.66M | -48.13%9.86M | -604.90%-18.55M |
| Net non-operating interest income expense | -215.34%-2.17M | -512.70%-2.01M | 108.35%223K | 54.72%-2.44M | 101.27%136K | -76.74%1.88M | 110.54%488K | -244.51%-2.67M | 12.30%-5.38M | 7.57%-10.7M |
| Non-operating interest income | -56.21%825K | 36.09%920K | 1,346.34%1.78M | 4,209.41%3.66M | 117.51%1.61M | -79.74%1.88M | 120.94%676K | -96.19%123K | 60.38%85K | 6.52%-9.21M |
| Non-operating interest expense | --3M | 1,034.48%1.97M | -44.33%1.56M | 11.31%5.96M | -2.68%1.34M | ---- | -87.11%174K | 102.68%2.8M | -12.03%5.36M | -15.08%1.38M |
| Total other finance cost | ---- | ---- | ---- | 27.62%134K | ---- | ---- | ---- | ---- | 11.70%105K | ---- |
| Other net income (expense) | 13.20%-421K | 311.37%5.08M | -57.82%-535K | 21.01%12.71M | 22.40%13.67M | 92.63%-485K | -137.72%-2.4M | 23.13%-339K | 2.97%10.51M | 15.92%11.17M |
| Gain on sale of security | --21K | ---- | ---- | -221.34%-3.9M | ---- | ---- | ---- | ---- | -78.50%3.22M | ---- |
| Earnings from equity interest | 8.87%-442K | -130.00%-299K | -57.82%-535K | 73.31%-289K | 257.21%665K | -340.91%-485K | -19.27%-130K | 23.13%-339K | -256.05%-1.08M | -331.15%-423K |
| Special income (charges) | ---- | ---- | ---- | 111.24%16.62M | ---- | ---- | ---- | ---- | 244.41%7.87M | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 6.56%4.66M | ---- | ---- | ---- | ---- | -19.66%4.38M | ---- |
| -Gain on sale of business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --12.24M | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --21.28M | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | -43.59%286K | ---- | ---- | ---- | ---- | --507K | ---- |
| Income before tax | -54.22%1.51M | -101.77%-60K | 0.30%-16.62M | -180.15%-12.01M | 88.77%-2.03M | -64.36%3.31M | -82.69%3.39M | -493.91%-16.67M | -35.06%14.99M | -1,143.39%-18.08M |
| Income tax | 1,722.93%2.55M | -43.98%1.16M | 6.49%-4.18M | -211.50%-1.46M | 131.63%1.09M | -188.20%-157K | -45.82%2.07M | -678.50%-4.47M | -81.46%1.31M | -946.06%-3.45M |
| Net income | -129.85%-1.03M | -192.34%-1.22M | -1.97%-12.45M | -177.14%-10.55M | 78.65%-3.12M | -61.94%3.46M | -91.62%1.32M | -452.73%-12.21M | -14.52%13.67M | -809.16%-14.63M |
| Net income continuous Operations | -129.85%-1.03M | -192.34%-1.22M | -1.97%-12.45M | -177.14%-10.55M | 78.65%-3.12M | -61.94%3.46M | -91.62%1.32M | -452.73%-12.21M | -14.52%13.67M | -809.16%-14.63M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -129.85%-1.03M | -192.34%-1.22M | -1.97%-12.45M | -177.14%-10.55M | 78.65%-3.12M | -61.94%3.46M | -91.62%1.32M | -452.73%-12.21M | -14.52%13.67M | -809.16%-14.63M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -129.85%-1.03M | -192.34%-1.22M | -1.97%-12.45M | -177.14%-10.55M | 78.65%-3.12M | -61.94%3.46M | -91.62%1.32M | -452.73%-12.21M | -14.52%13.67M | -809.16%-14.63M |
| Basic earnings per share | -140.00%-0.02 | -150.00%-0.01 | 0.00%-0.19 | -176.19%-0.16 | 77.27%-0.05 | -64.29%0.05 | -91.67%0.02 | -480.00%-0.19 | -16.00%0.21 | -833.33%-0.22 |
| Diluted earnings per share | -140.00%-0.02 | -150.00%-0.01 | 0.00%-0.19 | -184.21%-0.16 | 77.27%-0.05 | -61.54%0.05 | -90.91%0.02 | -480.00%-0.19 | -17.39%0.19 | -833.33%-0.22 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.